139 related articles for article (PubMed ID: 7754943)
1. Risk factors for the development of recurrent atrial fibrillation: role of pacing and clinical variables.
Reimold SC; Lamas GA; Cantillon CO; Antman EM
Am Heart J; 1995 Jun; 129(6):1127-32. PubMed ID: 7754943
[TBL] [Abstract][Full Text] [Related]
2. Clinical challenge. I: Control of recurrent symptomatic atrial fibrillation.
Reimold SC
Eur Heart J; 1996 Jul; 17 Suppl C():35-40. PubMed ID: 8809537
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation.
Brignole M; Menozzi C; Gasparini M; Bongiorni MG; Botto GL; Ometto R; Alboni P; Bruna C; Vincenti A; Verlato R;
Eur Heart J; 2002 Jun; 23(11):892-900. PubMed ID: 12042011
[TBL] [Abstract][Full Text] [Related]
4. Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs.
Antman EM; Beamer AD; Cantillon C; McGowan N; Friedman PL
J Am Coll Cardiol; 1990 Mar; 15(3):698-707. PubMed ID: 2303641
[TBL] [Abstract][Full Text] [Related]
5. Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation.
Reimold SC; Cantillon CO; Friedman PL; Antman EM
Am J Cardiol; 1993 Mar; 71(7):558-63. PubMed ID: 8438741
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation.
Bellandi F; Simonetti I; Leoncini M; Frascarelli F; Giovannini T; Maioli M; Dabizzi RP
Am J Cardiol; 2001 Sep; 88(6):640-5. PubMed ID: 11564387
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic effects of oral sotalol during both sinus rhythm and atrial fibrillation.
Alboni P; Razzolini R; Scarfò S; Paparella N; Fucà G; Pedini I; Chioin R
J Am Coll Cardiol; 1993 Nov; 22(5):1373-7. PubMed ID: 8227794
[TBL] [Abstract][Full Text] [Related]
8. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness.
Wang J; Bourne GW; Wang Z; Villemaire C; Talajic M; Nattel S
Circulation; 1993 Sep; 88(3):1030-44. PubMed ID: 8353865
[TBL] [Abstract][Full Text] [Related]
9. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease.
Sweeney MO; Bank AJ; Nsah E; Koullick M; Zeng QC; Hettrick D; Sheldon T; Lamas GA;
N Engl J Med; 2007 Sep; 357(10):1000-8. PubMed ID: 17804844
[TBL] [Abstract][Full Text] [Related]
10. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.
Roy D; Talajic M; Dorian P; Connolly S; Eisenberg MJ; Green M; Kus T; Lambert J; Dubuc M; Gagné P; Nattel S; Thibault B
N Engl J Med; 2000 Mar; 342(13):913-20. PubMed ID: 10738049
[TBL] [Abstract][Full Text] [Related]
11. Sotalol versus propafenone for long-term maintenance of normal sinus rhythm in patients with recurrent symptomatic atrial fibrillation.
Kochiadakis GE; Igoumenidis NE; Hamilos ME; Tzerakis PG; Klapsinos NC; Chlouverakis GI; Vardas PE
Am J Cardiol; 2004 Dec; 94(12):1563-6. PubMed ID: 15589019
[TBL] [Abstract][Full Text] [Related]
12. Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome. Relevance of clinical characteristics and pacing modalities.
Sgarbossa EB; Pinski SL; Maloney JD; Simmons TW; Wilkoff BL; Castle LW; Trohman RG
Circulation; 1993 Sep; 88(3):1045-53. PubMed ID: 8353866
[TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation: rate control often better than rhythm control.
Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
[TBL] [Abstract][Full Text] [Related]
14. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
[TBL] [Abstract][Full Text] [Related]
15. Quality of life variables in the selection of rate versus rhythm control in patients with atrial fibrillation: observations from the Canadian Trial of Atrial Fibrillation.
Dorian P; Mangat I
Card Electrophysiol Rev; 2003 Sep; 7(3):276-9. PubMed ID: 14739727
[TBL] [Abstract][Full Text] [Related]
16. Rhythm versus rate control after ablation and pacing for paroxysmal atrial fibrillation: clinical implications of the PAF 2 trial.
Brignole M
Card Electrophysiol Rev; 2003 Jun; 7(2):127-9. PubMed ID: 14618035
[TBL] [Abstract][Full Text] [Related]
17. Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation: the AFTherapy study.
Camm AJ; Sulke N; Edvardsson N; Ritter P; Albers BA; Ruiter JH; Lewalter T; Capucci PA; Hoffmann E;
Europace; 2007 Dec; 9(12):1110-8. PubMed ID: 18042619
[TBL] [Abstract][Full Text] [Related]
18. Atrial septal pacing in the prevention of paroxysmal atrial fibrillation refractory to antiarrhythmic drugs.
Kale M; Bennett DH
Int J Cardiol; 2002 Feb; 82(2):167-75. PubMed ID: 11853903
[TBL] [Abstract][Full Text] [Related]
19. Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy.
Saksena S; Prakash A; Ziegler P; Hummel JD; Friedman P; Plumb VJ; Wyse DG; Johnson E; Fitts S; Mehra R;
J Am Coll Cardiol; 2002 Sep; 40(6):1140-50; discussion 1151-2. PubMed ID: 12354441
[TBL] [Abstract][Full Text] [Related]
20. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
